icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Boston USA
March 8-11, 2020
Back grey_arrow_rt.gif
 
 
 
Islatravir Metabolic Outcomes in a Phase 2b Trial of Treatment-Naïve Adults with HIV-1
 
 
  CROI: Conference on Retroviruses and Opportunistic Infections; Boston, MA, USA; March
8-11, 2020
Reported by Jules Levin
 
Grace A. McComsey1; Jean-Michel Molina2; Yazdan
 
Yazdanpanah3; Edwin DeJesus4; Stephanie O. Klopfer5; Anjana Grandhi5; Karen Eves5; Todd A. Correll5; Michael N. Robertson5; Carey Hwang5; George J. Hanna5; Peter Sklar5 1University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, USA; 2University of Paris Diderot and St-Louis Hospital, Paris, France; 3Bichat Hospital, Paris, France; 4Orlando Immunology Center, Orlando, FL, USA; 5Merck & Co., Inc., Kenilworth, NJ, USA

0309201

0309202

0309203

0309204

0309205

0309206

0309207